Skip to main content

Table 4 Correlation between SNP frequencies and treatment outcomes

From: Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola

Treatment outcome

SNPs

pfmdr1 >copy

pfmdr1 86

pfmdr1 1246

Pfatp6 769

pfK13

N86

86Y

86 N + Y

D1246

1246Y

S769

769 N

wt

mutant

ACPR

74.1 % (n = 63)

17.6 % (n = 15)

8.2 % (n = 7)

99 % (n = 88)

1 % (n = 1)

100 % (n = 93)

0

100 % (n = 12)

0

13 % (n = 12/92)

Treatment failure

66.6 % (n = 6)

22.2 % (n = 2)

11.1 % (n = 1)

100 (n = 7)

0

100 % (n = 10)

0

100 % (n = 9)

0

11 % (n = 1/9)

Total (n)

69

17

8

95

1

103

0

21

0

13

  1. pfmdr1, Plasmodium falciparum multidrug resistance 1 gene, SNP, Single nucleotide polymorphism, Pfatp6, Plasmodium falciparum sarco/endoplasmic reticulum calcium-ATPase6 gene, K13, mutations in the PF3D7_1343700 kelch propeller domain (‘K13-propeller’); wt, wild type allele; mixed, mix infections, >copy, pfmdr1 amplifyed (with >1 copy)